4-[2-(2,6-Dimethylpiperidin-1-yl)-2-oxoethoxy]-3-methoxybenzaldehyde

Catalog No.: 
ACTDXY196
CAS No.: 
565193-48-8
Molecular Formula: 
C17H23NO4
Molecular Weight: 
305.37
4-[2-(2,6-Dimethylpiperidin-1-yl)-2-oxoethoxy]-3-methoxybenzaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$170.00InquiryInquiry
5g95%$497.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[2-(2,6-Dimethylpiperidin-1-yl)-2-oxoethoxy]-3-methoxybenzaldehyde
IUPAC Name4-(2-(2,6-dimethylpiperidin-1-yl)-2-oxoethoxy)-3-methoxybenzaldehyde
MDL No.MFCD03968035
Molecular FormulaC17H23NO4
Molecular Weight305.37
SMILESO=CC1=CC=C(OCC(N2C(C)CCCC2C)=O)C(OC)=C1
InChI KeyUSQRXJNEDRBRPG-UHFFFAOYSA-N
Synonym4-[2-(2,6-DIMETHYL-PIPERIDIN-1-YL)-2-OXO-ETHOXY]-3-METHOXY-BENZALDEHYDE;Benzaldehyde, 4-[2-(2,6-dimethyl-1-piperidinyl)-2-oxoethoxy]-3-methoxy-
CAS No.565193-48-8

Synthetic Route by SureRoute

1. ACTDXY196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDAEO034 route compound structure diagram
    ACDAEO034504-03-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTDXY196 route product structure diagram
    ACTDXY196565193-48-8
Inquiry

2. ACTDXY196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDAEO034 route compound structure diagram
    ACDAEO034504-03-0In Stock
  2. Plus
  3. ACHTLI546 route compound structure diagram
    ACHTLI5461660-19-1In Stock
  4. Then
  5. ACTDXY196 route product structure diagram
    ACTDXY196565193-48-8
Inquiry

3. ACTDXY196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTDXY196 route product structure diagram
    ACTDXY196565193-48-8
Inquiry

Comments (0)